Delisting riskPopularity #5,375
GDTC · NASDAQ · Biotechnology

CytoMed Therapeutics (GDTC)

Develops donor-derived and iPSC-based cell therapies for cancer.

$0.9066
vs last close−0.00 (−0.37%)